Keywords: Stemline Thera, Brain cancer vaccine, Pittsburg University, License

Stemline Therapeutics in-licenses Ph I/II brain cancer vaccine to expand pipeline

Article | 24 February 2011

Print This

US clinical stage biopharma company Stemline Therapeutics says that it now holds the license, from the University of Pittsburgh (Pitt), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in